Midazolam Hydrochloride Injection
Gland Pharma Limited · Unavailable · Reason: Other
Open FDA's page for this record- Update type
- Reverified
- Initial posting date
- 04/02/2020
- Package NDC
- 25021-661-10
- Generic name
- Midazolam Hydrochloride Injection
- Contact info
- Avet Pharmaceuticals, Inc.: 855-228-9470; Sagent Pharmaceuticals: 866-625-1618
- Availability
- Unavailable
- Related info
- Estimated recovery: TBD; Distributed by Sagent Pharmaceuticals
- Update date
- 10/21/2026
- Dosage form
- Injection
- Presentation
- Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 25021-661-10)
- Company name
- Gland Pharma Limited
- Shortage reason
- Other
- Status
- Current
- Therapeutic category
- Anesthesia, Neurology
- Harmonized identifiers (openFDA)
- Application number
- ANDA090850
- Brand name
- MIDAZOLAM
- Generic name
- MIDAZOLAM HYDROCHLORIDE
- Manufacturer name
- Sagent Pharmaceuticals
- Product NDC
- 25021-661
- Product type
- HUMAN PRESCRIPTION DRUG
- Route
- INTRAMUSCULAR, INTRAVENOUS
- Substance name
- MIDAZOLAM HYDROCHLORIDE
- RxCUI
- 311702
- SPL ID
- 002ea282-09ba-4d79-8bd1-94c9859f442b
- SPL set ID
- 880cac48-5c0f-49a9-8aef-3c9770bf5d84
- Package NDC
- 25021-661-10
- UNII
- W7TTW573JJ
